ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Polyporus Sclerotium

Also known as: Polyporus Sclerotium, Zhu Ling, Polyporus umbellatus

Overview

Polyporus Sclerotium refers to the hardened underground fungal structure (sclerotium) of *Polyporus umbellatus*, a medicinal mushroom traditionally used in East Asia. This sclerotium contains bioactive compounds such as steroids and polysaccharides, which are believed to contribute to its therapeutic effects. Historically, it has been employed in Traditional Chinese Medicine (TCM) primarily for its diuretic properties, promoting urine production, and for renal protection, addressing conditions like edema and various urinary disorders. While research is ongoing, current evidence, largely preclinical, suggests its potential in modulating renal metabolism and inflammation. The overall research maturity is moderate, with a need for more rigorous, high-quality clinical trials to definitively establish its efficacy and safety in human populations.

Benefits

The primary benefit of Polyporus Sclerotium, supported by preclinical studies, is its diuretic and renal protective effects. Experimental research indicates that it can promote diuresis and protect kidney function, potentially by modulating renal metabolism and inflammation. The strength of this evidence is currently moderate, primarily derived from animal and cell models, with limited high-quality human clinical trials. While its polysaccharide content suggests potential anti-inflammatory and immunomodulatory effects, clinical evidence for these secondary benefits is still limited. It is hypothesized to be beneficial for individuals with kidney disorders or fluid retention, but this requires further clinical validation. Due to the lack of large-scale randomized controlled trials, quantitative clinical effect sizes are not well established, and the time course for observing benefits in clinical settings remains undefined.

How it works

The mechanism of action for Polyporus Sclerotium is primarily attributed to the synergistic effects of its bioactive compounds, particularly steroids and polysaccharides. These compounds are believed to modulate renal tubular function and influence inflammatory pathways within the kidneys. Metabolomic and transcriptomic analyses in preclinical studies have shown that treatment with Polyporus Sclerotium can induce alterations in renal metabolic pathways, suggesting a direct impact on kidney function. While specific molecular targets are not fully elucidated, it is hypothesized that steroidal compounds may interact with steroid receptors, and polysaccharides could influence immune signaling, thereby contributing to its diuretic and renal protective effects. Its primary interaction is with the renal system, with possible secondary modulation of the immune system.

Side effects

Polyporus Sclerotium is generally considered safe based on its long history of traditional use and limited toxicity data. However, there are no well-documented common adverse effects reported in clinical literature, and uncommon or rare side effects are not well characterized due to the scarcity of extensive clinical data. Specific drug interactions are largely unknown; therefore, caution is advised when combining Polyporus Sclerotium with conventional diuretics or immunomodulatory drugs, as potential additive or antagonistic effects have not been studied. No formal contraindications have been established. Furthermore, its safety during pregnancy, lactation, and in pediatric populations has not been determined, and its use in these special populations is not recommended without medical supervision.

Dosage

The optimal dosage ranges for Polyporus Sclerotium have not been established through high-quality clinical trials. Traditional formulations vary widely, and clinical standardization is currently lacking. Consequently, a minimum effective dose and a maximum safe dose are unknown due to insufficient clinical safety and efficacy data. Traditionally, it has been used in chronic regimens, but specific timing considerations for modern clinical use are not standardized. Polyporus Sclerotium is typically administered as dried sclerotium powder or various extracts. Information regarding absorption factors, such as the impact of co-administration with food or other herbs on its bioavailability, is limited. No specific cofactors have been identified as necessary for its efficacy.

FAQs

Is Polyporus Sclerotium effective for kidney protection?

Preclinical evidence suggests potential renal benefits, but robust human clinical trials are needed to confirm its efficacy for kidney protection.

Is it safe to use Polyporus Sclerotium long-term?

Traditional use indicates long-term safety, but comprehensive clinical safety data, especially for prolonged use, are currently limited.

Can Polyporus Sclerotium be combined with other diuretics?

There is no clear evidence regarding its interaction with other diuretics. Medical supervision is recommended if considering such a combination.

How soon can benefits be expected from Polyporus Sclerotium?

The time frame for observing benefits is unknown. Traditional use suggests that effects may be gradual and require consistent, long-term administration.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC8851056/ – This preclinical study utilized metabolomic and transcriptomic analyses to investigate the effects of Polyporus Sclerotium. It identified steroids and polysaccharides as key bioactive compounds and demonstrated their role in inducing renal protective metabolic changes in animal and cell models, providing mechanistic insights into its potential benefits.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC7331568/ – This systematic review focused on the methodology for conducting clinical trials on Chinese herbal medicine. While it discussed various herbal formulations that might include Polyporus, it did not provide a direct meta-analysis or specific high-quality randomized controlled trials exclusively on Polyporus Sclerotium, highlighting the general lack of rigorous clinical data for many traditional herbs.